Revenue
2013
2014
2015
2018
2019
2021
2022
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2,250 | — | — | $2,073 | $2,628 | — | $34,485 | $46,755 | — | $23,546 | $5,708 | $2,456 | $1,213 | $3,926 | — | — | — |
| Research & development | $3.3M | $3.3M | $2.9M | $2.1M | $2.8M | $1.1M | $237,658 | $867,887 | $1.1M | $1.6M | $3.3M | $2.7M | $1.5M | $750,494 | $132,108 | — | — |
| Operating expenses | $8.5M | $7.9M | $15.8M | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating income | −$8.5M | −$7.9M | −$15.8M | −$15.4M | −$10.1M | −$3.2M | −$2.4M | −$5.0M | −$3.5M | −$7.5M | −$15.1M | −$16.0M | −$12.0M | −$2.7M | — | — | — |
| EBITDAderived | −$8.5M | −$7.9M | −$15.8M | −$15.4M | −$10.0M | −$3.2M | −$2.4M | −$5.0M | −$3.5M | −$7.4M | −$15.0M | −$15.9M | −$11.9M | −$2.7M | — | — | — |
| Net income | −$9.6M | −$8.9M | −$16.7M | −$16.3M | −$11.1M | −$14.6M | −$3.2M | −$6.0M | −$4.3M | −$7.7M | −$9.7M | −$16.0M | −$12.0M | −$2.7M | −$1.5M | −$2.2M | −$983,886 |
| Basic EPSper diluted share | -$0.09 | -$0.09 | -$0.14 | -$0.14 | -$0.10 | -$0.13 | -$0.04 | -$0.06 | -$0.05 | -$0.07 | -$0.14 | -$0.15 | -$0.14 | -$0.04 | -$0.03 | — | — |
| Diluted EPSper diluted share | -$0.09 | -$0.09 | -$0.14 | -$0.14 | -$0.10 | -$0.13 | -$0.04 | -$0.06 | -$0.05 | -$0.07 | -$0.14 | -$0.15 | -$0.14 | -$0.04 | -$0.03 | — | — |